Fenylacetylglutamín - nový biomarker z črevného mikrobiómu v predikcii kardiovaskulárneho rizika [he phenylacethylglutamine - a new biomarker from the intestinal microbiome and prediction of cardiovascular risk].
About the publication
Record:
DUKÁT, Andrej - PAYER, Juraj - KYSELOVIČ, Ján - KOLLER, Tomáš - KRIŠKA, Milan - BERNADIČ, Marián - ŠIMKO, Fedor. Fenylacetylglutamín - nový biomarker z črevného mikrobiómu v predikcii kardiovaskulárneho rizika [he phenylacethylglutamine - a new biomarker from the intestinal microbiome and prediction of cardiovascular risk]. In: Lekársky obzor. 2023. ISSN 0457-4214, Roč. 72, č. 3 (2023), s. 123-126.
(6 - H-index, 0.186 - SJR, Q4 - SJR Best Q)
(6 - H-index, 0.186 - SJR, Q4 - SJR Best Q)
Year:
2023
Category:
V3 - Scientific output of publication activity from the journal
Output type:
CLA - article
Authors:
DUKÁT Andrej
0 %
PAYER Juraj
0 %
0 %
KOLLER Tomáš
0 %
KRIŠKA Milan
0 %
BERNADIČ Marián
0 %
ŠIMKO Fedor
0 %
UVMP share:
0 %
Edition:
Lekársky obzor
Roč. 72, č. 3 (2023), s. 123-126
Country of issue:
Slovakia
ISSN:
0457-4214
Research area:
180 - Medical, pharmaceutical and non-medical health sciences
Field:
Group of study fields: Health sciences and fields aimed at improving the quality of life
Name of the field of study: pharmacy
Scientometrics:
6 - H-index, 0.186 - SJR, Q4 - SJR Best Q
Language:
slovak